Bitte beachten Sie, dass die von Ihnen aufgerufene Seite nicht in Ihrer Standardsprache vorliegt. Sie nutzen unsere Plattform nun in einer anderen Sprache.
Leading 10 U.S. therapy areas based on drug spending in 2020* (in billion U.S. dollars)
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you U.S. pharmaceutical industry
Contribution to global pharma
5
- Premium Statistic World pharmaceutical market distribution by submarket 2014-2023
- Premium Statistic World pharmaceutical sales 2020-2023 by region
- Basic Statistic Market share of the leading global pharmaceutical markets 2022
- Premium Statistic Top global pharmaceutical markets: growth rate 2022
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
Overview
6
- Premium Statistic U.S. total medicine spending 2002-2022
- Basic Statistic Leading therapy areas for U.S. drug spending 2020
- Premium Statistic U.S. top prescribed drugs based on sales 2022
- Premium Statistic Top pharma products by prescriptions U.S. 2021
- Premium Statistic Pharmaceutical channel distribution by U.S. spending 2017-2019
- Premium Statistic U.S. biopharmaceutical export volume 2002-2022
Companies
6
- Premium Statistic 2024 list of top U.S. biotech and pharmaceutical companies based on revenue
- Premium Statistic Pharmaceutical corporations by U.S. revenue 2022
- Basic Statistic AbbVie's revenue 2010-2023
- Premium Statistic Pfizer's total revenue 2006-2023
- Premium Statistic Bristol-Myers Squibb's revenue 2006-2023
- Premium Statistic Johnson & Johnson's total sales 2005-2023
Research and development
7
- Basic Statistic Research and development expenditure: U.S. pharmaceutical industry 1995-2022
- Premium Statistic U.S. pharma industry R&D spending as a percent of total revenues 1990-2022
- Basic Statistic Pharmaceuticals: cost of drug development in the U.S. since 1975
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2023
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Basic Statistic U.S. sales of new brand medicines 2012-2021
- Basic Statistic R&D expenditure per employee in U.S. sectors 2003-2017
Generics
5
- Basic Statistic Spending change on branded and generic medicines in the U.S. 2014-2021
- Premium Statistic U.S. brand and generic prescription drug spending 2017-2021
- Premium Statistic Branded vs. generic U.S. drug prescriptions dispensed 2005-2021
- Premium Statistic Savings through generic drug usage in the U.S. 2008-2022
- Premium Statistic Sales share at risk of pharmaceuticals due to patent expiries U.S. 2022
Public view on pharma
6
- Premium Statistic Share of U.S. people who had a favorable view of pharmaceutical companies 2021
- Premium Statistic U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
- Premium Statistic Share of U.S. adults who approve pharmaceutical companies' drug price handling 2021
- Basic Statistic Share of people who had a favorable view of Pfizer in U.S. 2021
- Basic Statistic Share of people who had a favorable view of Moderna in U.S. 2021
- Premium Statistic Share of people who had a favorable view of J&J in U.S. 2021
Outlook
4
- Premium Statistic World pharmaceutical sales by region forecast 2027
- Premium Statistic Sales at risk of pharmaceuticals due to patent expiries U.S. 2022
- Basic Statistic Leading U.S. pharmaceutical products by revenue 2026
- Basic Statistic U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection
Further related statistics
18
- New medicine availability by therapy area worldwide 2013
- Drugs in development with potential to be first-in-class in 2016, by therapeutic area
- Volume of the ten best-selling drugs in France 2015, by active ingredient
- Volume of the ten best-selling drugs in France 2015, by packaging
- Payment method for prescriptions dispensed in the U.S. 2016-2021
- Distribution of Sino Biopharm revenue 2022, by product category
- Global pharmaceutical pipeline by therapy area 2013-2017
- Rx medicine out-of-pocket expense per person in the U.S. 1987-2014
- Global pharmaceutical product launches by therapy area 2004-2013
- U.S. costs saved through generics by therapy 2004-2013
- Total and per capita change in U.S. prescriptions 2004-2013
- Top therapy spending areas in pharmerging markets 2018
- Prescription per capita in the United States by age group 2013
- Prescribed medicines usage in the Netherlands 2021, by type
- Reasons for rejected payer retail prescriptions in the U.S. in select classes 2013
- Monthly value of medicament exports from Iceland 2022-2023
- Children's medicine recalls by manufacturer in the U.S. 2015
- Oncology medicines sales in the United States 2010-2019
Further Content: You might find this interesting as well
Statistics
- New medicine availability by therapy area worldwide 2013
- Drugs in development with potential to be first-in-class in 2016, by therapeutic area
- Volume of the ten best-selling drugs in France 2015, by active ingredient
- Volume of the ten best-selling drugs in France 2015, by packaging
- Payment method for prescriptions dispensed in the U.S. 2016-2021
- Distribution of Sino Biopharm revenue 2022, by product category
- Global pharmaceutical pipeline by therapy area 2013-2017
- Rx medicine out-of-pocket expense per person in the U.S. 1987-2014
- Global pharmaceutical product launches by therapy area 2004-2013
- U.S. costs saved through generics by therapy 2004-2013
- Total and per capita change in U.S. prescriptions 2004-2013
- Top therapy spending areas in pharmerging markets 2018
- Prescription per capita in the United States by age group 2013
- Prescribed medicines usage in the Netherlands 2021, by type
- Reasons for rejected payer retail prescriptions in the U.S. in select classes 2013
- Monthly value of medicament exports from Iceland 2022-2023
- Children's medicine recalls by manufacturer in the U.S. 2015
- Oncology medicines sales in the United States 2010-2019
IQVIA. (May 27, 2021). Leading 10 U.S. therapy areas based on drug spending in 2020* (in billion U.S. dollars) [Graph]. In Statista. Retrieved May 21, 2024, from https://www.statista.com/statistics/238698/us-health-spending-leading-areas/
IQVIA. "Leading 10 U.S. therapy areas based on drug spending in 2020* (in billion U.S. dollars)." Chart. May 27, 2021. Statista. Accessed May 21, 2024. https://www.statista.com/statistics/238698/us-health-spending-leading-areas/
IQVIA. (2021). Leading 10 U.S. therapy areas based on drug spending in 2020* (in billion U.S. dollars). Statista. Statista Inc.. Accessed: May 21, 2024. https://www.statista.com/statistics/238698/us-health-spending-leading-areas/
IQVIA. "Leading 10 U.S. Therapy Areas Based on Drug Spending in 2020* (in Billion U.S. Dollars)." Statista, Statista Inc., 27 May 2021, https://www.statista.com/statistics/238698/us-health-spending-leading-areas/
IQVIA, Leading 10 U.S. therapy areas based on drug spending in 2020* (in billion U.S. dollars) Statista, https://www.statista.com/statistics/238698/us-health-spending-leading-areas/ (last visited May 21, 2024)
Leading 10 U.S. therapy areas based on drug spending in 2020* (in billion U.S. dollars) [Graph], IQVIA, May 27, 2021. [Online]. Available: https://www.statista.com/statistics/238698/us-health-spending-leading-areas/